96 related articles for article (PubMed ID: 16185500)
1. [Expression of Oct2 and its significance in lymphoma diagnosis].
Zhao XR; Ma DL
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):337-40. PubMed ID: 16185500
[TBL] [Abstract][Full Text] [Related]
2. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
[TBL] [Abstract][Full Text] [Related]
3. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma.
Browne P; Petrosyan K; Hernandez A; Chan JA
Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905
[TBL] [Abstract][Full Text] [Related]
4. [Apoptosis-antagonizing protein Bcl-2 expression, distribution in non-Hodgkin's lymphoma and its clinical significance].
Chen X; Huang G; Wang W
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):140-2. PubMed ID: 10743081
[TBL] [Abstract][Full Text] [Related]
5. [T-cell/histiocyte-rich B-cell lymphoma: histology, immunophenotype and differential diagnosis].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Luo XL
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):771-5. PubMed ID: 16545182
[TBL] [Abstract][Full Text] [Related]
6. [Expression of B cell-specific activator protein in lymphomas].
Li D; Li GD; Liu WP; Li FY; Zhang WY; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):345-7. PubMed ID: 16185503
[TBL] [Abstract][Full Text] [Related]
7. Variable expression of B-cell transcription factors in reactive immunoblastic proliferations: a potential mimic of classical Hodgkin lymphoma.
Treetipsatit J; Rimzsa L; Grogan T; Warnke RA; Natkunam Y
Am J Surg Pathol; 2014 Dec; 38(12):1655-63. PubMed ID: 24921642
[TBL] [Abstract][Full Text] [Related]
8. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
[TBL] [Abstract][Full Text] [Related]
9. B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).
Johnson RC; Ma L; Cherry AM; Arber DA; George TI
Am J Clin Pathol; 2013 Sep; 140(3):355-62. PubMed ID: 23955454
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
[TBL] [Abstract][Full Text] [Related]
11. [Expression of fragile histidine triad (FHIT) protein and its significance in diagnosing classical Hodgkin lymphoma].
Zhao P; Lü YL; Zhong M; Chen LH; Pu XL
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):289-91. PubMed ID: 16777001
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of bcl-6 protein expression and gene rearrangement in diffuse large B-cell lymphoma].
Min DL; Xia HL; Zhou XY; Sun MH; Yang WT; Zhang TM; Zheng AH; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):327-31. PubMed ID: 16185497
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of BIOMED-2 assays for detection of clonal Ig gene rearrangements in mature B-cell lymphomas].
Zhang J; Wu YH; Kong HY; Zhou XG; Jin HS; Wu XM; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):739-44. PubMed ID: 20079012
[TBL] [Abstract][Full Text] [Related]
14. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.
Dorfman DM; Brown JA; Shahsafaei A; Freeman GJ
Am J Surg Pathol; 2006 Jul; 30(7):802-10. PubMed ID: 16819321
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
16. Protein expression pattern distinguishes different lymphoid neoplasms.
Fujii K; Kondo T; Yokoo H; Yamada T; Matsuno Y; Iwatsuki K; Hirohashi S
Proteomics; 2005 Nov; 5(16):4274-86. PubMed ID: 16206328
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma].
Zhou X; Zhao T; Qi Z; Liu G; Zhu M
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1532-5. PubMed ID: 12609061
[TBL] [Abstract][Full Text] [Related]
18. IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.
Prakash S; Fountaine T; Raffeld M; Jaffe ES; Pittaluga S
Am J Surg Pathol; 2006 May; 30(5):585-92. PubMed ID: 16699312
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic study of 369 B-cell non-Hodgkin lymphoma cases, with reference to the 2001 World Health Organization classification of lymphoid neoplasms].
Zhang YN; Zhou XG; Zhang SH; Wang P; Zhang CH; Huang SF
Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):193-7. PubMed ID: 16091170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
